Related Experiment Videos
Enalapril: a long-acting angiotensin-converting enzyme inhibitor
M Borek1, S Charlap, W Frishman
1Department of Medicine, Long Island College Hospital, Brooklyn, New York.
Pharmacotherapy
|January 1, 1987
Abstract:
The development of angiotensin-converting enzyme (ACE) inhibitors is of landmark importance in the understanding and treatment of cardiovascular disorders, particularly hypertension and congestive heart failure. Enalapril has recently joined captopril as an approved, orally active ACE inhibitor. Like captopril, it has been effective in the treatment of hypertension and congestive heart failure, with minimal adverse reactions noted. Differences in pharmacology exist between enalapril and captopril which may prove to be of clinical significance.